1279691-36-9

• 常用中文名：甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-alpha-D-吡喃葡萄糖苷
• 常用英文名：Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside
• CAS号：1279691-36-9
• 分子式：C₂₄H₂₉ClO₈
• 分子量：480.935
• 相关类别： 医药中间体 原料药中间体
• 发布时间：2018-12-26 17:13:21
• 更新时间：2026-07-14 19:16:22

名称

• 中文名: 甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-alpha-D-吡喃葡萄糖苷
• 英文名: Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-alpha-D-glucopyranoside
• 中文别名: 高级中间体EG5-OMe; 恩格列净中间体2; 依帕列净甲氧基物; 甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-ALPHA-D-吡喃葡萄糖苷; 1,5-脱水-1-甲氧基-1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-D-葡萄糖醇; 甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基; 甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-ALPHA-D-吡喃葡萄糖; 恩格列净N-1; (2S,3R,4S,5S,6R)-2-(4-氯-3-(4-(((S)-四氢呋喃-3-基)氧基)苄基)苯基)-6-(羟甲基)-2-甲氧基四氢-2H-吡喃-3,4,5-三醇; LC02-IN2恩格列净杂质85; 甲基1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-ALPHA-D-吡喃葡萄糖苷(依帕列净中间体); (2S,3R,4S,5S,6R)-2-(4-氯-3-(4-(((S)-3-四氢呋喃)氧代)苄基)苯基)-6-(羟甲基)-2-甲氧基四氢-2H-吡喃-3,4,5-三醇; 甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基…; 恩格列净 5; 甲基1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-Α-D-吡喃葡萄糖苷; 依帕列净杂质85; 化合物 (2S,3R,4S,5S,6R)-2-(4-CHLORO-3-(4-(((S)-TETRAHYDROFURAN-3-YL)OXY)BENZYL)PHENYL)-6-(HYDROXYMETHYL)-2-METHOXYTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; 依帕列净杂质21; 艾格列净中间体; 恩格列净杂质97; 恩格列净INT3
• 英文别名: Methyl 1-C-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-α-D-glucopyranoside; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyM; Methy11-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3- furanyl]oxy]phenyl]methy1]pheny1]-alpha-D- glucopyranoside; Methyl1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol; Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-a-D-glucopyranoside; (3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol (%）; Empagliflozin Intermediates; (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol; Empagliflozin Intermediate3; Empagliflozin Intermediate 85; α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]; Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-α-D-glucopyranoside; 1-C-[4-chloro-3-[[4-[[(3S)-t etrahydro-3-furanyl]oxy]ph enyl]methyl]phenyl]-alpha- D-glucopyranoside; l)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol; Methyl 1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]Methyl]phenyl]-alpha-D-glucopyranoside; Empagliflozin N-1; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)- 4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy; (3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-met; (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol ISO 9001：2015 REACH; (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

物化性质

• 密度: 1.4±0.1 g/cm3
• 沸点: 663.4±55.0 °C at 760 mmHg
• 分子式: C₂₄H₂₉ClO₈
• 分子量: 480.935
• 闪点: 355.0±31.5 °C
• 精确质量: 480.155090
• PSA: 117.84000
• LogP: 4.54
• 蒸汽压: 0.0±2.1 mmHg at 25°C
• 折射率: 1.640
• 储存条件: 2-8°C， 密封， 干燥